Alzheimer’s disease is characterized by advanced and incapacitating dementia in aging individuals, and the pathogenesis of the disease involves an irregular buildup of tau proteins and amyloid-beta peptides in the neurons and extracellular space of particular regions of the brain [133]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.